Largest Biotechnology companies in Netherlands by Market Capitalization
Netherlands
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 40.28 B |
Jan. 14, 2025 | USD 673.61 | 1.66% |
|
Netherlands |
|
| 2 |
USD 10.13 B |
Jan. 14, 2025 | USD 45.57 | -0.94% |
|
Netherlands |
|
| 3 |
USD 2.67 B |
Jan. 14, 2025 | USD 39.01 | -3.56% |
|
Netherlands |
|
| 4 |
USD 2.53 B |
Jan. 14, 2025 | USD 23.67 | -3.70% |
|
Netherlands |
|
| 5 |
USD 1.33 B |
Jan. 14, 2025 | USD 22.92 | 2.26% |
|
Netherlands |
|
| 6 |
USD 867.73 M |
Jan. 14, 2025 | USD 16.00 | -2.50% |
|
Netherlands |
|
| 7 |
USD 706.98 M |
Jan. 14, 2025 | USD 13.23 | -4.06% |
|
Netherlands |
|
| 8 |
USD 673.99 M |
Jan. 14, 2025 | USD 9.93 | 5.98% |
|
Netherlands |
|
| 9 |
USD 239.35 M |
Jan. 14, 2025 | USD 2.26 | -0.44% |
|
Netherlands |
|
| 10 |
USD 25.77 M |
Jan. 14, 2025 | USD 0.98 | -1.01% |
|
Netherlands |
Frequently Asked Questions
-
Which Biotechnology company in Netherlands has the highest Market Capitalization ?
The Biotechnology company in Netherlands with the highest Market Capitalization is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 40.28 B.
-
Which Biotechnology company in Netherlands has the lowest Market Capitalization ?
The Biotechnology company in Netherlands with the lowest Market Capitalization is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD 25.77 M.
-
What are the top 10 Biotechnology companies in Netherlands by Market Capitalization ?
The top 10 Biotechnology companies in Netherlands by Market Capitalization are argenx SE, Qiagen N.V., Merus N.V., NewAmsterdam Pharma Company N.V., Corbion N.V., Pharvaris N.V., uniQure N.V., Pharming Group N.V., ProQR Therapeutics N.V. and LAVA Therapeutics N.V..
-
What are the bottom 10 Biotechnology companies in Netherlands by Market Capitalization ?
The bottom 10 Biotechnology companies in Netherlands by Market Capitalization are LAVA Therapeutics N.V., ProQR Therapeutics N.V., Pharming Group N.V., uniQure N.V., Pharvaris N.V., Corbion N.V., NewAmsterdam Pharma Company N.V., Merus N.V., Qiagen N.V. and argenx SE.